The estimated Net Worth of Pamela M Arway is at least $4.09 Миллион dollars as of 9 October 2023. Ms. Arway owns over 182 units of DaVita Inc stock worth over $2,396,238 and over the last 16 years she sold DVA stock worth over $1,310,098. In addition, she makes $380,765 as Independent Chairman of the Board at DaVita Inc.
Pamela has made over 35 trades of the DaVita Inc stock since 2010, according to the Form 4 filled with the SEC. Most recently she sold 182 units of DVA stock worth $35,410 on 9 October 2023.
The largest trade she's ever made was exercising 24,000 units of DaVita Inc stock on 7 June 2018 worth over $1,561,920. On average, Pamela trades about 676 units every 22 days since 2009. As of 9 October 2023 she still owns at least 15,561 units of DaVita Inc stock.
You can see the complete history of Ms. Arway stock trades at the bottom of the page.
Pamela M. Arway has been appointed as Independent Chairman of the Board of the Company effective 6/1/2020. Ms. Arway has been one of our directors since May 2009. From 2005 to 2008, Ms. Arway served as the president of the Japan, Asia-Pacific, Australia region for American Express International, Inc., a global payment services and travel company. Ms. Arway joined the American Express Company in 1987, and subsequently served in various capacities, including as chief executive officer of American Express Australia Limited from 2004 to 2005 and as executive vice president of Corporate Travel, North America from 2000 to 2004. Prior to her retirement in October 2008, she also served as advisor to the American Express Company’s chairman and chief executive officer. Since May 2010, Ms. Arway has been a member of the board of The Hershey Company, a chocolate and confectionery company. She currently serves as a member of the Compensation and Finance and Risk Management Committees of The Hershey Company's board. Since March 2014, Ms. Arway has been a member of the board of Iron Mountain Incorporated, an enterprise information management services company and currently serves as chair of its Compensation Committee and as a member of the Nominating and Governance Committee. Ms. Arway brings significant leadership experience as a global executive, with extensive management experience in the areas of marketing, international business, finance and government affairs. With her service as a director on the boards of other large public companies, Ms. Arway also brings significant experience in corporate governance and executive compensation related matters.
As the Independent Chairman of the Board of DaVita Inc, the total compensation of Pamela Arway at DaVita Inc is $380,765. There are 12 executives at DaVita Inc getting paid more, with Javier Rodriguez having the highest compensation of $16,853,500.
Pamela Arway is 66, she's been the Independent Chairman of the Board of DaVita Inc since 2020. There are 2 older and 18 younger executives at DaVita Inc. The oldest executive at DaVita Inc is John Nehra, 71, who is the Independent Director.
Over the last 22 years, insiders at DaVita Inc have traded over $539,813,199 worth of DaVita Inc stock and bought 20,841,023 units worth $1,590,012,094 . The most active insiders traders include Hathaway Incbuffett Warren ..., R. Ted Weschler, и Kent J Thiry. On average, DaVita Inc executives and independent directors trade stock every 12 days with the average trade being worth of $12,626,872. The most recent stock trade was executed by Kathleen Alyce Waters on 28 August 2024, trading 26,333 units of DVA stock currently worth $1,999,991.
about davita kidney care davita kidney care is a division of davita healthcare partners inc., a fortune 500® company that, through its operating divisions, provides a variety of health care services to patient populations throughout the united states and abroad. a leading provider of dialysis services in the united states, davita kidney care treats patients with chronic kidney failure and end stage renal disease. davita kidney care strives to improve patients' quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. as of march 31, 2015, davita kidney care operated or provided administrative services at 2,197 outpatient dialysis centers located in the united states serving approximately 174,000 patients. the company also operated 93 outpatient dialysis centers located in 10 countries outside the united states. davita kidney care supports numerous programs dedicated to creating positive,
DaVita Inc executives and other stock owners filed with the SEC include: